News

CenterWell Pharmacy (a part of Humana Inc.) announced plans to develop end-to-end employer prescription solutions with Cost Plus Drugs.

The GUARD Financial Data Act would have the most impact on information not covered by HIPAA.

One case involved a plan administrator that updated claim-processing systems for medical benefits but not for mental health benefits.

Pharmaceutical Strategies Group survey finds employers and health plans prioritizing cost control and cross-benefit management, with growing willingness to trade rebates for stronger utilization oversight amid rising complexity and CGT concerns.

In a letter, Democrats told acting Labor Secretary Keith Sonderling Friday to revive the 2024 rule.

Capital Blue Cross is partnering with the Mark Cuban Cost Plus Drug Co. to make lower‑cost biosimilar alternatives to Humira and Stelara available to commercial members.